Abstract
Bone graft procedures typically require surgeons to harvest bone from a second site on a given patient (Autograft) before repairing a bone defect. However, this results in increased surgical time, excessive blood loss and a significant increase in pain. In this context a synthetic bone graft with excellent histocompatibility, built in antibacterial efficacy and the ability to regenerate healthy tissue in place of diseased tissue would be a significant step forward relative to current state of the art philosophies. We developed a range of calcium–strontium–zinc–silicate glass based bone grafts and characterised their structure and physical properties, then evaluated their in vitro cytotoxicity and in vivo biocompatibility using standardised models from the literature. A graft (designated BT109) of composition 0.28SrO/0.32ZnO/0.40 SiO2 (mol fraction) was the best performing formulation in vitro shown to induce extremely mild cytopathic effects (cell viability up to 95%) in comparison with the commercially available bone graft Novabone® (cell viability of up to 72%). Supplementary to this, the grafts were examined using the standard rat femur healing model on healthy Wister rats. All grafts were shown to be equally well tolerated in bone tissue and new bone was seen in close apposition to implanted particles with no evidence of an inflammatory response within bone. Complimentary to this BT109 was implanted into the femurs of ovariectomized rats to monitor the response of osteoporotic tissue to the bone grafts. The results from this experiment indicate that the novel grafts perform equally well in osteoporotic tissue as in healthy tissue, which is encouraging given that bone response to implants is usually diminished in ovariectomized rats. In conclusion these materials exhibit significant potential as synthetic bone grafts to warrant further investigation and optimisation.
Similar content being viewed by others
References
C.T. Laurencin, Y. Khan, Bone Grafts and Bone Graft Substitutes: A Brief Histrory (Bridgeport, New Jersey, 2003)
A.S. Greenwald, S.D. Boden, V.M. Goldberg, Y. Khan, C.T. Laurencin, R.N. Rosier, J. Bone Joint Surg. Am 83, 98 (2001)
T.J. Cypher, J.P. Grossman, J. Foot Ankle Surg. 35, 413 (1996)
E.M. Younger, M.W. Chapman, J. Orthop. Trauma 3, 192 (1989). doi:10.1097/00005131-198909000-00002
W.R. Moore, S.E. Graves, G.I. Bain, ANZ J. Surg. 71, 354 (2001). doi:10.1046/j.1440-1622.2001.02128.x
Frost and Sullivan Market Report, U.S. Bone Graft and Bone Graft Substitutes (Frost and Sullivan, 2002)
D.I. Ilan, A.L. Ladd, Oper. Tech. Plast. Reconstr. Surg. 9, 151 (2003). doi:10.1053/j.otpr.2003.09.003
Control CFD, Update: Allograft-associated Bacterial Infections––United States. MMWR 51:207 (2002)
R.J. Simonds, S.D. Holmberg, R.L. Hurwitz, S. Bottenfield, L.J. Conley, S.H. Kohlenberg et al., N. Engl. J. Med. 326, 726 (1992)
M.C. von Doernberg, B. von Rechenberg, M. Bohner, S. Grunenfelder, G.H. van Lenthe, R. Muller et al., Biomaterials 27, 5186 (2006). doi:10.1016/j.biomaterials.2006.05.051
K.A. Hing, L.F. Wilson, T. Buckland, J. Spine (in press)
W.H. Bell, Oral Surg. 17, 405 (1964). doi:10.1016/0030-4220(64)90372-X
J.R. Jones, L.M. Ehrenfried, L.L. Hench, Biomaterials 27, 964 (2006). doi:10.1016/j.biomaterials.2005.07.017
D.L. Wheeler, kE Stokes, R.G. Hoellrich, D.L. Chamberlain, S.W. McLoughlin, J. Biomed. Mater. Res. 41, 527 (1998). doi:10.1002/(SICI)1097-4636(19980915)41:4<527::AID-JBM3>3.0.CO;2-E
J.R. Jones, L.L. Hench, Curr. Opin. Solid State Mater. Sci. 7, 301 (2003). doi:10.1016/j.cossms.2003.09.012
I. Kinnunen, K. Aitsalo, M. Pollonen, M. Varpula, J. Craniomaxillofac. Surg. 28, 229 (2000). doi:10.1054/jcms.2000.0140
Fairbank J, in 17th Interdisciplinary Research Conference On Biomaterials (Oxford, UK, 2007)
D. Boyd, H. Li, D.A. Tanner, M.R. Towler, G.J. Wall, J. Mater. Sci. Mater. Med. 17, 489 (2006). doi:10.1007/s10856-006-8930-6
W.R. Holloway, F.M. Collier, R.E. Herbst, J.M. Hodge, G.C. Nicholson, Bone 19, 137 (1996). doi:10.1016/8756-3282(96)00141-X
J.P. Marie, Bone 40, S5 (2007). doi:10.1016/j.bone.2007.02.003
A. Guida, M.R. Towler, G.J. Wall, R.G. Hill, S. Eramo, J. Mat, Sci. Lett. 22, 1401 (2003)
International Standard 10993-5, Biological Evaluation of Medical Devices Part 5: Tests for In Vitro Cytotoxicity (International Organization Standardization, Case Postale 56, CH-1211, Geneve, Switzerland, 1999)
D. Boyd, M.R. Towler, S. Watts, R.G. Hill, A.W. Wren, O.M. Clarkin, J. Mater. Sci. Mater. Med. 19, 953 (2008). doi:10.1007/s10856-006-0060-7
D. Boyd, M.R. Towler, R.V. Law, R.G. Hill, J. Mater. Sci. Mater. Med. 17, 397 (2006). doi:10.1007/s10856-006-8465-x
R. Zange, T. Kissel, Eur. J. Pharm. Biopharm. 44, 149 (1997). doi:10.1016/S0939-6411(97)00082-9
J. Pan, T. Shirota, K. Ohno, K. Michi, J. Oral Maxillofac. Surg. 58, 877 (2000). doi:10.1053/joms.2000.8212
M. Motahashi, T. Shirota, Y. Tokugawa, K. Ohno, K. Michi, A. Yamaguchi, Oral Surg. Oral Med. Oral Pathol. 87, 145 (1999)
T. Shirota, K. Ohno, K. Suzuki, K. Michi, J. Oral Maxillofac. Surg. 51, 51 (1993)
K. Murai, F. Takeshita, Y. Ayukawa, T. Kiyoshima, T. Suetsugu, T. Tanaka, J. Biomed. Mater. Res. 30, 523 (1996). doi:10.1002/(SICI)1097-4636(199604)30:4<523::AID-JBM11>3.0.CO;2-I
F. Takeshita, K. Murai, Y. Ayukawa, T. Suetsugu, J. Biomed. Mater. Res. 34, 1 (1997). doi:10.1002/(SICI)1097-4636(199701)34:1<1::AID-JBM1>3.0.CO;2-V
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Boyd, D., Carroll, G., Towler, M.R. et al. Preliminary investigation of novel bone graft substitutes based on strontium–calcium–zinc–silicate glasses. J Mater Sci: Mater Med 20, 413–420 (2009). https://doi.org/10.1007/s10856-008-3569-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10856-008-3569-0